A citation-based method for searching scientific literature

Mikihito Hayashi, Tomoki Nakashima, Masahiko Taniguchi, Tatsuhiko Kodama, Atsushi Kumanogoh, Hiroshi Takayanagi. Nature 2012
Times Cited: 327







List of co-cited articles
1032 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Sema3A regulates bone-mass accrual through sensory innervations.
Toru Fukuda, Shu Takeda, Ren Xu, Hiroki Ochi, Satoko Sunamura, Tsuyoshi Sato, Shinsuke Shibata, Yutaka Yoshida, Zirong Gu, Ayako Kimura,[...]. Nature 2013
197
24

Suppression of bone formation by osteoclastic expression of semaphorin 4D.
Takako Negishi-Koga, Masahiro Shinohara, Noriko Komatsu, Haruhiko Bito, Tatsuhiko Kodama, Roland H Friedel, Hiroshi Takayanagi. Nat Med 2011
275
23

Bidirectional ephrinB2-EphB4 signaling controls bone homeostasis.
Chen Zhao, Naoko Irie, Yasunari Takada, Kouji Shimoda, Takeshi Miyamoto, Toru Nishiwaki, Toshio Suda, Koichi Matsuo. Cell Metab 2006
488
16

Evidence for osteocyte regulation of bone homeostasis through RANKL expression.
Tomoki Nakashima, Mikihito Hayashi, Takanobu Fukunaga, Kosaku Kurata, Masatsugu Oh-Hora, Jian Q Feng, Lynda F Bonewald, Tatsuhiko Kodama, Anton Wutz, Erwin F Wagner,[...]. Nat Med 2011
942
15

Semaphorin III is needed for normal patterning and growth of nerves, bones and heart.
O Behar, J A Golden, H Mashimo, F J Schoen, M C Fishman. Nature 1996
487
14

Osteoclast-secreted CTHRC1 in the coupling of bone resorption to formation.
Sunao Takeshita, Toshio Fumoto, Kazuhiko Matsuoka, Kyoung-ae Park, Hiroyuki Aburatani, Shigeaki Kato, Masako Ito, Kyoji Ikeda. J Clin Invest 2013
120
11

OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis.
Y Y Kong, H Yoshida, I Sarosi, H L Tan, E Timms, C Capparelli, S Morony, A J Oliveira-dos-Santos, G Van, A Itie,[...]. Nature 1999
11

Osteoclast differentiation and activation.
William J Boyle, W Scott Simonet, David L Lacey. Nature 2003
10

Osteoprotegerin: a novel secreted protein involved in the regulation of bone density.
W S Simonet, D L Lacey, C R Dunstan, M Kelley, M S Chang, R Lüthy, H Q Nguyen, S Wooden, L Bennett, T Boone,[...]. Cell 1997
10

Matrix-embedded cells control osteoclast formation.
Jinhu Xiong, Melda Onal, Robert L Jilka, Robert S Weinstein, Stavros C Manolagas, Charles A O'Brien. Nat Med 2011
766
10

Semaphorin signaling in bone.
Lieve Verlinden, Dirk Vanderschueren, Annemieke Verstuyf. Mol Cell Endocrinol 2016
26
38

Expression of Semaphorin-3A and its receptors in endochondral ossification: potential role in skeletal development and innervation.
C Gomez, B Burt-Pichat, F Mallein-Gerin, B Merle, P D Delmas, T M Skerry, L Vico, L Malaval, C Chenu. Dev Dyn 2005
72
13

Regulation of bone formation by osteoclasts involves Wnt/BMP signaling and the chemokine sphingosine-1-phosphate.
Larry Pederson, Ming Ruan, Jennifer J Westendorf, Sundeep Khosla, Merry Jo Oursler. Proc Natl Acad Sci U S A 2008
321
9

TGF-beta1-induced migration of bone mesenchymal stem cells couples bone resorption with formation.
Yi Tang, Xiangwei Wu, Weiqi Lei, Lijuan Pang, Chao Wan, Zhenqi Shi, Ling Zhao, Timothy R Nagy, Xinyu Peng, Junbo Hu,[...]. Nat Med 2009
675
9

The Role of Semaphorin 3A in Bone Remodeling.
Zhenxia Li, Jin Hao, Xin Duan, Nan Wu, Zongke Zhou, Fan Yang, Juan Li, Zhihe Zhao, Shishu Huang. Front Cell Neurosci 2017
30
30

Osteoporosis: now and the future.
Tilman D Rachner, Sundeep Khosla, Lorenz C Hofbauer. Lancet 2011
9

Semaphorins in bone development, homeostasis, and disease.
Sujin Kang, Atsushi Kumanogoh. Semin Cell Dev Biol 2013
53
16

Matrix IGF-1 maintains bone mass by activation of mTOR in mesenchymal stem cells.
Lingling Xian, Xiangwei Wu, Lijuan Pang, Michael Lou, Clifford J Rosen, Tao Qiu, Janet Crane, Frank Frassica, Liming Zhang, Juan Pablo Rodriguez,[...]. Nat Med 2012
344
8

Leptin regulates bone formation via the sympathetic nervous system.
Shu Takeda, Florent Elefteriou, Regis Levasseur, Xiuyun Liu, Liping Zhao, Keith L Parker, Dawna Armstrong, Patricia Ducy, Gerard Karsenty. Cell 2002
8

PDGF-BB secreted by preosteoclasts induces angiogenesis during coupling with osteogenesis.
Hui Xie, Zhuang Cui, Long Wang, Zhuying Xia, Yin Hu, Lingling Xian, Changjun Li, Liang Xie, Janet Crane, Mei Wan,[...]. Nat Med 2014
332
8

Osteoblast-derived WNT16 represses osteoclastogenesis and prevents cortical bone fragility fractures.
Sofia Movérare-Skrtic, Petra Henning, Xianwen Liu, Kenichi Nagano, Hiroaki Saito, Anna E Börjesson, Klara Sjögren, Sara H Windahl, Helen Farman, Bert Kindlund,[...]. Nat Med 2014
180
8

Bone cell communication factors and Semaphorins.
Takako Negishi-Koga, Hiroshi Takayanagi. Bonekey Rep 2012
53
15

Coupling of bone resorption and formation by RANKL reverse signalling.
Yuki Ikebuchi, Shigeki Aoki, Masashi Honma, Madoka Hayashi, Yasutaka Sugamori, Masud Khan, Yoshiaki Kariya, Genki Kato, Yasuhiko Tabata, Josef M Penninger,[...]. Nature 2018
171
8


Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation.
D L Lacey, E Timms, H L Tan, M J Kelley, C R Dunstan, T Burgess, R Elliott, A Colombero, G Elliott, S Scully,[...]. Cell 1998
7

Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL.
H Yasuda, N Shima, N Nakagawa, K Yamaguchi, M Kinosaki, S Mochizuki, A Tomoyasu, K Yano, M Goto, A Murakami,[...]. Proc Natl Acad Sci U S A 1998
7


Plexin-A1 and its interaction with DAP12 in immune responses and bone homeostasis.
Noriko Takegahara, Hyota Takamatsu, Toshihiko Toyofuku, Tohru Tsujimura, Tatsusada Okuno, Kazunori Yukawa, Masayuki Mizui, Midori Yamamoto, Durbaka V R Prasad, Kazuhiro Suzuki,[...]. Nat Cell Biol 2006
181
7


Costimulatory signals mediated by the ITAM motif cooperate with RANKL for bone homeostasis.
Takako Koga, Masanori Inui, Kazuya Inoue, Sunhwa Kim, Ayako Suematsu, Eiji Kobayashi, Toshio Iwata, Hiroshi Ohnishi, Takashi Matozaki, Tatsuhiko Kodama,[...]. Nature 2004
589
7

Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts.
Hiroshi Takayanagi, Sunhwa Kim, Takako Koga, Hiroshi Nishina, Masashi Isshiki, Hiroki Yoshida, Akio Saiura, Miho Isobe, Taeko Yokochi, Jun-ichiro Inoue,[...]. Dev Cell 2002
7

Semaphorin signaling in cardiovascular development.
Jonathan A Epstein, Haig Aghajanian, Manvendra K Singh. Cell Metab 2015
58
12

Bone resorption by osteoclasts.
S L Teitelbaum. Science 2000
7



Calcitonin-gene-related peptide stimulates stromal cell osteogenic differentiation and inhibits RANKL induced NF-kappaB activation, osteoclastogenesis and bone resorption.
Liping Wang, Xiaoyou Shi, Rong Zhao, Bernard P Halloran, David J Clark, Christopher R Jacobs, Wade S Kingery. Bone 2010
102
7

Substance P stimulates bone marrow stromal cell osteogenic activity, osteoclast differentiation, and resorption activity in vitro.
Liping Wang, Rong Zhao, Xiaoyou Shi, Tzuping Wei, Bernard P Halloran, David J Clark, Christopher R Jacobs, Wade S Kingery. Bone 2009
87
8

Autoregulation of Osteocyte Sema3A Orchestrates Estrogen Action and Counteracts Bone Aging.
Mikihito Hayashi, Tomoki Nakashima, Noriko Yoshimura, Kazuo Okamoto, Sakae Tanaka, Hiroshi Takayanagi. Cell Metab 2019
47
14

The bone lining cell: its role in cleaning Howship's lacunae and initiating bone formation.
V Everts, J M Delaissé, W Korper, D C Jansen, W Tigchelaar-Gutter, P Saftig, W Beertsen. J Bone Miner Res 2002
195
6

Osteoclast-specific cathepsin K deletion stimulates S1P-dependent bone formation.
Sutada Lotinun, Riku Kiviranta, Takuma Matsubara, Jorge A Alzate, Lynn Neff, Anja Lüth, Ilpo Koskivirta, Burkhard Kleuser, Jean Vacher, Eero Vuorio,[...]. J Clin Invest 2013
204
6

Anabolic bone formation via a site-specific bone-targeting delivery system by interfering with semaphorin 4D expression.
Yufeng Zhang, Lingfei Wei, Richard J Miron, Bin Shi, Zhuan Bian. J Bone Miner Res 2015
54
11

Sphingosine 1-phosphate as a regulator of osteoclast differentiation and osteoclast-osteoblast coupling.
Jiyoon Ryu, Hyung Joon Kim, Eun-Ju Chang, Hao Huang, Yoshiko Banno, Hong-Hee Kim. EMBO J 2006
201
6

Increased bone density in sclerosteosis is due to the deficiency of a novel secreted protein (SOST).
W Balemans, M Ebeling, N Patel, E Van Hul, P Olson, M Dioszegi, C Lacza, W Wuyts, J Van Den Ende, P Willems,[...]. Hum Mol Genet 2001
765
6

Osteoclast-derived complement component 3a stimulates osteoblast differentiation.
Kazuhiko Matsuoka, Kyoung-Ae Park, Masako Ito, Kyoji Ikeda, Sunao Takeshita. J Bone Miner Res 2014
84
7

Semaphorins and plexins as therapeutic targets.
Thomas Worzfeld, Stefan Offermanns. Nat Rev Drug Discov 2014
159
6

Autoamplification of NFATc1 expression determines its essential role in bone homeostasis.
Masataka Asagiri, Kojiro Sato, Takako Usami, Sae Ochi, Hiroshi Nishina, Hiroki Yoshida, Ikuo Morita, Erwin F Wagner, Tak W Mak, Edgar Serfling,[...]. J Exp Med 2005
586
6

Endothelial and perivascular cells maintain haematopoietic stem cells.
Lei Ding, Thomas L Saunders, Grigori Enikolopov, Sean J Morrison. Nature 2012
6


Romosozumab Treatment in Postmenopausal Women with Osteoporosis.
Felicia Cosman, Daria B Crittenden, Jonathan D Adachi, Neil Binkley, Edward Czerwinski, Serge Ferrari, Lorenz C Hofbauer, Edith Lau, E Michael Lewiecki, Akimitsu Miyauchi,[...]. N Engl J Med 2016
553
6

Semaphorin signalling during development.
Bart C Jongbloets, R Jeroen Pasterkamp. Development 2014
104
6


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.